Appropriately, the overexpression of miR 103a-3p resulted in a reduction of CXCL12 protein levels in the bloodstream and inhibited venous thrombosis in mice, thus providing further support of the concept (95). The gene discussed is CXCL12; the disease is Venous thrombosis.